Gain Therapeutics Inc. (GANX) Stock Holdings & Institutional Ownership

Gain Therapeutics Inc.

GANX

Super Fund	Position	Shares	Curr. Value	Port. %	Activity
DME Capital Management	Equity	566,130	$1,002,050	0.04%	0%

Total Shares Held: 566,130

Total Value Reported: $1,002,050

Average Allocation per Portfolio 0.04%

Largest Single Portfolio Allocation: 0.04%

Largest Shareholder: DME Capital Management

Change in Total Shares Held (Q on Q): +0

Percentage Change in Shares Held (Q on Q): 0.00%

Number of Current Holders: 1

Number of New Holders (Q on Q): 0

Number of Funds with Additions (Q on Q): 0

Number of Funds with Reductions (Q on Q): 0

Number of Funds Fully Divested (Q on Q): 0

Number of Funds with No Change (Q on Q): 1